Literature DB >> 11043688

Analysis of risk factors for the development of equine protozoal myeloencephalitis in horses.

W J Saville1, S M Reed, P S Morley, D E Granstrom, C W Kohn, K W Hinchcliff, T E Wittum.   

Abstract

OBJECTIVE: To investigate risk factors for development of equine protozoal myeloencephalitis (EPM) in horses.
DESIGN: Case-control study. ANIMALS: 251 horses admitted to The Ohio State University Veterinary Teaching Hospital from 1992 to 1995. PROCEDURE: On the basis of clinical signs of neurologic disease and detection of antibody to Sarcocystis neurona or S neurona DNA in cerebrospinal fluid, a diagnosis of EPM was made for 251 horses. Two contemporaneous series of control horses were selected from horses admitted to the hospital. One control series (n = 225) consisted of horses with diseases of the neurologic system other than EPM (neurologic control horses), and the other consisted of 251 horses admitted for reasons other than nervous system diseases (nonneurologic control horses). Data were obtained from hospital records and telephone conversations. Risk factors associated with disease status were analyzed, using multivariable logistic regression.
RESULTS: Horses ranged from 1 day to 30 years old (mean +/- SD, 5.7 +/- 5.2 years). Risk factors associated with an increased risk of developing EPM included age, season of admission, prior diagnosis of EPM on the premises, opossums on premises, health events prior to admission, and racing or showing as a primary use. Factors associated with a reduced risk of developing EPM included protection of feed from wildlife and proximity of a creek or river to the premises where the horse resided. CONCLUSIONS AND CLINICAL RELEVANCE: Development of EPM was associated with a number of management-related factors that can be altered to decrease the risk for the disease.

Entities:  

Mesh:

Year:  2000        PMID: 11043688     DOI: 10.2460/javma.2000.217.1174

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  5 in total

1.  Reduced levels of nitric oxide metabolites in cerebrospinal fluid are associated with equine protozoal myeloencephalitis.

Authors:  Chinedu J Njoku; William J A Saville; Stephen M Reed; Michael J Oglesbee; Päivi J Rajala-Schultz; Roger W Stich
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

2.  Molecular characterization of Sarcocystis neurona strains from opossums (Didelphis virginiana) and intermediate hosts from Central California.

Authors:  Daniel Rejmanek; Melissa A Miller; Michael E Grigg; Paul R Crosbie; Patricia A Conrad
Journal:  Vet Parasitol       Date:  2010-02-11       Impact factor: 2.738

3.  Effects of Experimental Sarcocystis neurona-Induced Infection on Immunity in an Equine Model.

Authors:  S Rochelle Lewis; Siobhan P Ellison; John J Dascanio; David S Lindsay; Robert M Gogal; Stephen R Werre; Naveen Surendran; Meghan E Breen; Bettina M Heid; Frank M Andrews; Virginia A Buechner-Maxwell; Sharon G Witonsky
Journal:  J Vet Med       Date:  2014-11-12

Review 4.  Equine Protozoal Myeloencephalitis: An Updated Consensus Statement with a Focus on Parasite Biology, Diagnosis, Treatment, and Prevention.

Authors:  S M Reed; M Furr; D K Howe; A L Johnson; R J MacKay; J K Morrow; N Pusterla; S Witonsky
Journal:  J Vet Intern Med       Date:  2016-02-09       Impact factor: 3.333

5.  Can levamisole upregulate the equine cell-mediated macrophage (M1) dendritic cell (DC1) T-helper 1 (CD4 Th1) T-cytotoxic (CD8) immune response in vitro?

Authors:  Sharon Witonsky; Virginia Buechner-Maxwell; Amy Santonastasto; Robert Pleasant; Stephen Werre; Bettina Wagner; Siobhan Ellison; David Lindsay
Journal:  J Vet Intern Med       Date:  2019-01-29       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.